GEN IC REQUEST TEMPLATE
Data to Support Drug Product Communications (CDER)
OMB Control Number 0910-0695
BEFORE SUBMISSION
Ensure that your Gen IC meets the requirements of the umbrella generic. This generic facilitates FDA’s ability to assess the need for communications on specific topics and to assist in the development and modification of communication messages.
All
documents submitted with this gen IC should indicate FDA sponsorship
and display the current OMB approval expiration date.
HOW TO USE THIS TEMPLATE
This template utilizes fill-in enabled text form fields. Simply click on the shaded text and enter your narrative.
United
States Food and Drug Administration
Testing Communications on
Drug Products (CDER)
OMB Control Number 0910-0695
Gen IC
Request for Approval
Title of Gen IC: Provide the name of the collection of information that is the subject of the request.
Statement of Need
Provide a brief description of the purpose of this collection.
Intended
Use of the Information
Indicate
how the information will be used and if this is part of a larger
study or effort.
Description of Respondents
Describe participants/respondents.
How the Information is Collected
Provide details about how the information will be collected (e.g., individual in-depth interviews, focus group, intercept interviews, self-admnistered survey, omnibus survey) and who (e.g., contractor) will facilitate.
Confidentiality
of Respondents
Describe any assurance of confidentiality provided to respondents.
[You may provide this statement on your survey instrument]: “Your participation / nonparticipation is completely voluntary, and your responses will not have an effect on your eligibility for receipt of any FDA services. In instances where respondent identity is needed (e.g., for follow-up of non-respondents), this information collection fully complies with all aspects of the Privacy Act and data will be kept private to the fullest extent allowed by law.”
Amount and Justification for Proposed Incentive
What is the amount, if any, of the incentive offered? Provide a detailed justification as to why this group of respondents for this information collection will receive a stipend, reimbursement of expenses, token of appreciation.
Questions of a Sensitive Nature
Describe and provide justification.
Description
of Statistical Methods
Describe
sample size and method of selection.
Burden
Replace the content of the example table below with the estimated burden for this gen IC.
Participation
time may be in the format of hours or minutes (use a decimal) and
indicated in the heading.
Burden
Hour Computation:
Number of Respondents multiplied by participation time = total burden
hours. Data
in all fields of the table must be entered, including totals.
Be sure not to double count respondents. In the example
below the Number of Respondents is 200 because focus group
respondents have been counted as part of the focus group screener
respondents. (The focus group respondents are part of the screener
group.) Round up to whole numbers for the total burden hours; do not
use decimals. Delete
this italicized instruction prior to submission.
|
Number of Respondents |
Participation Time (choose hours or minutes) |
Total Burden (hours) |
Focus group screener respondents |
200 |
1 hour |
200 |
Focus group respondents |
120 |
1 hour |
120 |
Totals |
200 |
2 hours |
320 |
Date(s) to be Conducted
[Insert date(s) and locations, if applicable.]
Requested Approval Date
Insert
date if shorter than 10 day turn-around time as noted in the SSA.
Otherwise use the month and year, only, allowing for a 30 day review
time at APRA.
FDA Contacts
Program Office Contact |
FDA PRA Contact |
[Insert name, phone number.] Center for Drug Evaluation and Research |
[PRA Staff will insert name, phone number and center.] Paperwork Reduction Act Staff Office of Enterprise Management Services Office of Operations |
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Capezzuto, JonnaLynn |
File Modified | 0000-00-00 |
File Created | 2024-07-25 |